Zeng-li Liu
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Correction: HMGB1 correlates with angiogenesis and poor prognosis of perihilar cholangiocarcinoma via elevating VEGFR2 of vessel endothelium.
Journal: Oncogene
Published: July 29, 2025
Prognostic analysis of lymph node resection and liver resection for T1b and T2 gallbladder cancer: a multi-center retrospective study.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: December 29, 2024
EEF1AKMT4-eEF1A2 synergistically facilitates the progression of GBC by promoting ribosomal protein output.
Journal: Genes & diseases
Published: November 03, 2024
Advances in molecular and cell therapy for immunotherapy of cholangiocarcinoma.
Journal: Frontiers in oncology
Published: January 13, 2023
Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers.
Journal: Frontiers in immunology
Published: September 21, 2022
Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma.
Journal: Experimental and therapeutic medicine
Published: January 19, 2020
Downregulation of EVI1 Expression Inhibits Cell Proliferation and Induces Apoptosis in Hilar Cholangiocarcinoma via the PTEN/AKT Signalling Pathway.
Journal: Journal of Cancer
Published: November 30, 2018
Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling.
Journal: Journal of cellular and molecular medicine
Published: May 18, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026